SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Cardiology Consultation — Zora Neale Hurston
| Patient | Zora Neale Hurston |
|---|
| Date of birth | 1959-01-07 |
|---|
| Identifiers | MRN HR-ML040-SYN; SSN (made up) 000-40-6213 |
|---|
| Document date | 2026-03-23 |
|---|
| Author | Tomasz Okafor-Whitfield, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
Breathlessness on exertion, mild ankle swelling and stage 2 blood pressure in a 67-year-old woman, with left ventricular hypertrophy on ECG and a raised NT-proBNP. Please confirm whether this is hypertensive heart disease with heart failure with preserved ejection fraction, exclude its mimics, and advise on treatment. [S]
Urgency: Soon; on the day of her two-week visit, after the echocardiogram that morning. [S]
Questions for the consultant:
- Is the breathlessness due to hypertensive heart disease with heart failure with preserved ejection fraction?
- Are there features of a mimic or another cause, such as cardiac amyloidosis, valve disease or coronary disease, and does she need further testing?
- Is chlorthalidone with amlodipine the right combination for her, and what blood pressure target do you advise?
- Which heart failure medicines do you recommend, and in what order, given her costs?
- What is her stroke risk, and does she need screening for atrial fibrillation?
History of Present Illness
Ms. Hurston, a 67-year-old writer and substitute teacher, is seen at the request of Dr. Abernathy-Osei on the day of her echocardiogram. She has been breathless on one flight of stairs for about three months, with ankle swelling by evening and morning headaches that have gone since she started blood pressure medicines a week ago. She has no chest pain, palpitations, fainting, orthopnea or night breathlessness, no numbness of the hands, and no known kidney or thyroid disease. She has never smoked and drinks rarely. She gave a clear, precise history and asked to understand every recommendation. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Zora Neale Hurston was born on January 7, 1891, in Notasulga, Alabama, the fifth of eight children of John Hurston, a carpenter and Baptist preacher, and Lucy Potts Hurston, a former schoolteacher. [D]
- She was born as Zora Lee Hurston, according to the Florida Artists Hall of Fame. [D]
- Her family moved to Eatonville, Florida, the nation's first incorporated Black township, when she was a toddler (at about three, in 1894), and her father later became its mayor; for her, Eatonville was always home. [D]
- Her mother died in 1904, when Zora was 13. [D]
- In 1917, aged 26 and needing to present herself as a teenager to qualify for free public schooling in Baltimore, she gave her age as 16 and her birth year as 1901; from then on she presented herself as at least ten years younger than she was. The headstone placed on her grave in 1973 reads 1901. [D]
- She attended Howard University and Barnard College, where she studied anthropology with Franz Boas and received a bachelor of arts degree in 1928; she did folklore field work in the South and became a writer and anthropologist of the Harlem Renaissance. [D]
- Over more than 30 years she published four novels, including Their Eyes Were Watching God (1937), two books of folklore, an autobiography, and many stories, essays, articles and plays. [D]
- She never received the financial rewards her work deserved; the largest royalty she earned from any of her books was $943.75. [D]
- In 1950 she worked as a maid in Florida while still publishing in national magazines, and she struggled to find work throughout the 1950s. [D]
- She worked as a librarian at Patrick Air Force Base in Florida (from June 1956 by one account, for about a year by another) and then moved to Fort Pierce, where she wrote a column on "Hoodoo and Black Magic" for the Fort Pierce Chronicle from 1957 to 1959; a family friend from Eatonville invited her to live in a small house in Fort Pierce rent-free. [D]
- In 1958 she worked as a substitute teacher at Lincoln Park Academy in Fort Pierce. [D]
- Rarely a drinker, she was remembered by friends for her humor and storytelling and for the gift of walking into hearts. [D]
3 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Amlodipine 5 mg oral tablet, one tablet every morning | One tablet every morning | Oral route | 2026-03-09 | active | S |
| Chlorthalidone 25 mg oral tablet, one-half tablet (12.5 mg) every morning | One-half tablet every morning | Oral route | 2026-03-09 | active | S |
| Dapagliflozin 10 mg oral tablet, one tablet daily; pause on days of vomiting, diarrhea or not eating or drinking | One tablet daily, with sick-day rules | Oral route | 2026-03-23 | active | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-23 | active | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Very high blood pressure at intake (178/104 and 174/102 mmHg) with morning headaches for two months, without signs of a hypertensive emergency; not previously diagnosed; ambulatory monitoring to confirm | resolved | confirmed |
R03.0 | S — Synthetic presenting problem, resolved when ambulatory monitoring and the echocardiogram established the diagnosis at the second visit. Not a claim about her real blood pressure. |
| Breathlessness on exertion for three months (walking to the school, carrying groceries) with mild ankle swelling by evening; cause to be determined | resolved | confirmed |
R06.09 | S — Synthetic presenting problem, resolved into the heart failure diagnosis at the second visit. |
| Hypertensive heart disease with heart failure: stage 2 hypertension confirmed by 24-hour ambulatory monitoring (mean 158/96 mmHg, non-dipping at night), with concentric left ventricular hypertrophy on ECG and echocardiogram; synthetic modern episode linked to the hypertensive heart disease recorded as her cause of death | active | confirmed |
I11.0 | S — Synthetic modern diagnosis made at the second visit; the 1960 cause of death remains D. |
| Heart failure with preserved ejection fraction (ejection fraction 62%), NYHA class II, with grade II diastolic dysfunction and an enlarged left atrium | active | confirmed |
I50.32 | S — Synthetic modern diagnosis confirmed by echocardiogram and cardiology at the second visit. |
| Food insecurity: food runs short at the end of most months (Hunger Vital Sign positive) | active | confirmed |
Z59.41 | S — Synthetic social need anchored to her documented poverty. |
| Low and irregular income from substitute teaching and newspaper writing, with Original Medicare but no drug coverage; medicine costs a barrier | active | confirmed |
Z59.6 | S — Synthetic social need anchored to her documented low income in the 1950s. |
Physical Exam
Vital signs recorded on 2026-03-23; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|
| General | Well; blood pressure 150/90, pulse 78; weight 83.4 kg |
| Neck | Jugular venous pressure not raised; no carotid bruits |
| Cardiovascular | Regular rhythm; sustained apical impulse; S4; no murmur |
| Respiratory | Clear |
| Extremities | Trace ankle edema |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2026-03-23 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-03-23 | Potassium [Moles/volume] in Serum or Plasma | 3.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-23 | Creatinine [Mass/volume] in Serum or Plasma | 0.94 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-03-23 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 67 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-03-23 | Glucose [Mass/volume] in Serum or Plasma | 98 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-03-23 | Magnesium [Mass/volume] in Serum or Plasma | 1.9 | mg/dL | 1.6-2.6 mg/dL | Normal | S |
| 2026-03-23 | Left ventricular Ejection fraction | 62 | % | 50-70% | Normal | S |
| 2026-03-23 | Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area | 38 | mL/m2 | <=34 mL/m² | High | S |
| 2026-03-23 | Heart valve E velocity/Annulus E wave by US | 15 | {ratio} | <=14 | High | S |
| 2026-03-23 | Overall summary score [KCCQ-12] | 54 | {score} | | | S |
Assessment
- Heart failure with preserved ejection fraction (I50.32). Yes. Exertional breathlessness with a raised NT-proBNP, an ejection fraction of 62%, an enlarged left atrium and an E/e' of 15 meet the criteria for HFpEF; her H2FPEF score is 5 of 9 (obesity 2, two blood pressure medicines 1, age over 60 1, E/e' above 9 1; estimated pulmonary artery systolic pressure 34 mmHg, below the 35 mmHg cut point), which makes HFpEF very likely. NYHA class II. [S]
- Cause and mimics (I11.0). The cause is hypertensive heart disease: high blood pressure, untreated and probably present for years, concentric hypertrophy and ECG voltage that matches the wall thickness. Transthyretin cardiac amyloidosis, including the hereditary form more common in Black Americans, should be kept in mind in HFpEF with a thick heart, but she has none of its red flags: no low voltage, no carpal tunnel or nerve symptoms, no aortic stenosis and only modest wall thickening. No technetium scan or light-chain tests are needed now; they would be if the walls thicken further or symptoms worsen despite controlled blood pressure. The valves are normal. With no angina and no Q waves or regional wall motion abnormality, stress testing is not needed. [S]
- Blood pressure treatment (I11.0). Chlorthalidone with amlodipine is the right start: the 2025 guideline advises two drugs for stage 2 hypertension, and a thiazide-type diuretic with a calcium channel blocker for Black adults without kidney disease or albuminuria. The diuretic also helps her mild congestion. Target below 130/80 mmHg. If blood pressure stays above target or potassium falls on chlorthalidone, add spironolactone 12.5 mg, which also has some benefit in HFpEF. [S]
- Heart failure medicines and cost (I50.32). An SGLT2 inhibitor is the first heart failure medicine to add now; it lowers heart failure hospitalization in HFpEF. Dapagliflozin or empagliflozin are equally good; use whichever she can get, through patient assistance until Extra Help begins. Spironolactone is second, as above. Sacubitril-valsartan is not needed while blood pressure can be controlled with low-cost generics. A moderate-intensity statin is reasonable for primary prevention given her blood pressure, hypertrophy and LDL. [S]
- Stroke risk and atrial fibrillation. Her greatest risk is stroke: untreated stage 2 hypertension with left ventricular hypertrophy and non-dipping at night. Blood pressure control lowers that risk the most. There is no atrial fibrillation on the ECG; she does not need prolonged monitoring now, but pulse checks at visits and an ECG for any palpitations are advised, since a large left atrium raises her future risk. She should know the BE FAST signs and call 911. [S]
Data reviewed: Dr. Abernathy-Osei's intake note. ECG from intake: sinus rhythm, left ventricular hypertrophy by voltage with repolarization changes, no Q waves. 24-hour ambulatory blood pressure before treatment: mean 158/96 mmHg, daytime 163/99, night 149/90, non-dipping. Home average 146/88 after one week of chlorthalidone and amlodipine. Echocardiogram this morning: ejection fraction 62%, concentric left ventricular hypertrophy (septum 13 mm, posterior wall 12 mm), grade II diastolic dysfunction with average E/e' 15, left atrial volume index 38 mL/m2, tricuspid regurgitation velocity 2.8 m/s with a normal inferior vena cava (estimated pulmonary artery systolic pressure 34 mmHg), no significant valve disease. NT-proBNP 480 pg/mL. Metabolic panel today: potassium 3.6 mmol/L, creatinine 0.94 mg/dL (eGFR 67). Urine albumin-to-creatinine ratio 22 mg/g. LDL 132 mg/dL. [S]
Plan of Treatment
- Continue chlorthalidone 12.5 mg and amlodipine 5 mg daily; target below 130/80 mmHg with home readings. [S]
- Start dapagliflozin 10 mg daily now, with sick-day rules, through the manufacturer's patient assistance program until her drug coverage begins. [S]
- If blood pressure stays above target or potassium falls below 3.5 mmol/L, add spironolactone 12.5 mg daily. [S]
- Metabolic panel one to two weeks after each start or dose change, then every three to six months. [S]
- Atorvastatin 20 mg daily. [S]
- No stress test, technetium scan or light-chain testing now; reconsider if symptoms or wall thickness progress. [S]
- Daily weights with a written plan; walking most days (cardiac rehabilitation is not covered for HFpEF under Medicare's criteria). [S]
- Pulse check at each visit and an ECG for palpitations; teach BE FAST. [S]
- Repeat echocardiogram only with an unexplained change in her condition. [S]
- Discussed with Dr. Abernathy-Osei, who saw her the same day. The diagnosis, the reasons for each medicine and their costs were explained to Ms. Hurston, who agreed to dapagliflozin and atorvastatin today and to spironolactone if needed. [S]
- Follow-up: Dr. Abernathy-Osei continues her care. Cardiology review in six months, or sooner if breathlessness worsens, the ejection fraction or blood pressure changes unexpectedly, or palpitations appear. [S]